Mouse PD-L1 : Mouse PD-1 [Biotinylated] Inhibitor Screening ELISA Kit
背景(Background)
Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.
原理(Assay Principles)
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new Mouse PD-L1 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated Mouse PD-1 to immobilized Mouse PD-L1 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a Mouse Biotinylated PD-1 protein, a Mouse PD-L1 protein, an anti-Mouse PD-L1 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.
Your experiment will include 4 simple steps:
a) Coat the plate with Mouse PD-L1.
b) Add your molecule of interest to the tests.
c) Add Mouse PD-1-Biotin to bind the coated Mouse PD-L1.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
e) Finally, the half maximal inhibitory concentration (IC50) of your compound to PD-1: PD-L1 binding will be determined by comparing OD readings among different experimental groups.
應(yīng)用說明(Application)
This kit is developed for screening for inhibitors of Mouse PD-L1 binding to Mouse PD-1.
It is for research use only.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
存儲(Storage)
Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
關(guān)鍵字: PD-1/PD-L1 ELISA Kit;PD-1/PD-L1試劑盒;PD-1/PD-L1 ELISA試劑盒;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。